Pugazhendhi Vijayaraman1, ShunmugaSundaram Ponnusamy2, Óscar Cano3, Parikshit S Sharma4, Angela Naperkowski5, Faiz A Subsposh5, Pawel Moskal5, Agnieszka Bednarek6, Alexander R Dal Forno7, Wilson Young5, Sudip Nanda8, Dominik Beer5, Bengt Herweg9, Marek Jastrzebski6. 1. Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, USA. Electronic address: pvijayaraman1@geisinger.edu. 2. Division of Cardiology, Velammal Medical College, Madurai, India. 3. Division of Cardiology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. 4. Rush University Medical Center, Chicago, Illinois, USA. 5. Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, USA. 6. First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University, Medical College, Krakow, Poland. 7. SOS Cardio Hospital, Florinapolis, Brazil. 8. Division of Cardiology, St. Luke's University Health System, Bethlehem, Pennsylvania, USA. 9. Division of Cardiology, University of South Florida, Tampa, Florida, USA.
Abstract
OBJECTIVES: The aim of this study was to assess the feasibility and outcomes of left bundle branch area pacing (LBBAP) in patients eligible for cardiac resynchronization therapy (CRT) in an international, multicenter, collaborative study. BACKGROUND: CRT using biventricular pacing is effective in patients with heart failure and left bundle branch block (LBBB). LBBAP has been reported as an alternative option for CRT. METHODS: LBBAP was attempted in patients with left ventricular ejection fraction (LVEF) <50% and indications for CRT or pacing. Procedural outcomes, left bundle branch capture, New York Heart Association functional class, heart failure hospitalization, echocardiographic data, and lead complications were recorded. Clinical (no heart failure hospitalization and improvement in New York Heart Association functional class) and echocardiographic responses (≥5% improvement in LVEF) were assessed. RESULTS: LBBAP was attempted in 325 patients, and CRT was successfully achieved in 277 (85%) (mean age 71 ± 12 years, 35% women, ischemic cardiomyopathy in 44%). QRS configuration at baseline was LBBB in 39% and non-LBBB in 46%. Procedure and fluoroscopy duration were 105 ± 54 and 19 ± 15 min, respectively. LBBAP threshold and R-wave amplitudes were 0.6 ± 0.3 V at 0.5 ms and 10.6 ± 6 mV at implantation and remained stable during mean follow-up of 6 ± 5 months. LBBAP resulted in significant QRS narrowing from 152 ± 32 to 137 ± 22 ms (p < 0.01). LVEF improved from 33 ± 10% to 44 ± 11% (p < 0.01). Clinical and echocardiographic responses were observed in 72% and 73% of patients, respectively. Baseline LBBB (odds ratio: 3.96; 95% confidence interval: 1.64 to 9.26; p < 0.01) and left ventricular end-diastolic diameter (odds ratio: 0.62; 95% confidence interval: 0.49 to 0.79; p < 0.01) were independent predictors of echocardiographic response. CONCLUSIONS: LBBAP is feasible and safe and provides an alternative option for CRT. LBBAP provides remarkably low and stable pacing thresholds and was associated with improved clinical and echocardiographic outcomes.
OBJECTIVES: The aim of this study was to assess the feasibility and outcomes of left bundle branch area pacing (LBBAP) in patients eligible for cardiac resynchronization therapy (CRT) in an international, multicenter, collaborative study. BACKGROUND: CRT using biventricular pacing is effective in patients with heart failure and left bundle branch block (LBBB). LBBAP has been reported as an alternative option for CRT. METHODS: LBBAP was attempted in patients with left ventricular ejection fraction (LVEF) <50% and indications for CRT or pacing. Procedural outcomes, left bundle branch capture, New York Heart Association functional class, heart failure hospitalization, echocardiographic data, and lead complications were recorded. Clinical (no heart failure hospitalization and improvement in New York Heart Association functional class) and echocardiographic responses (≥5% improvement in LVEF) were assessed. RESULTS: LBBAP was attempted in 325 patients, and CRT was successfully achieved in 277 (85%) (mean age 71 ± 12 years, 35% women, ischemic cardiomyopathy in 44%). QRS configuration at baseline was LBBB in 39% and non-LBBB in 46%. Procedure and fluoroscopy duration were 105 ± 54 and 19 ± 15 min, respectively. LBBAP threshold and R-wave amplitudes were 0.6 ± 0.3 V at 0.5 ms and 10.6 ± 6 mV at implantation and remained stable during mean follow-up of 6 ± 5 months. LBBAP resulted in significant QRS narrowing from 152 ± 32 to 137 ± 22 ms (p < 0.01). LVEF improved from 33 ± 10% to 44 ± 11% (p < 0.01). Clinical and echocardiographic responses were observed in 72% and 73% of patients, respectively. Baseline LBBB (odds ratio: 3.96; 95% confidence interval: 1.64 to 9.26; p < 0.01) and left ventricular end-diastolic diameter (odds ratio: 0.62; 95% confidence interval: 0.49 to 0.79; p < 0.01) were independent predictors of echocardiographic response. CONCLUSIONS: LBBAP is feasible and safe and provides an alternative option for CRT. LBBAP provides remarkably low and stable pacing thresholds and was associated with improved clinical and echocardiographic outcomes.
Authors: Kyeongmin Byeon; Hye Ree Kim; Seung-Jung Park; Young Jun Park; Ji-Hoon Choi; Ju Youn Kim; Kyoung-Min Park; Young Keun On; June Soo Kim Journal: J Clin Med Date: 2022-04-28 Impact factor: 4.964
Authors: Baldeep S Sidhu; Justin Gould; Mark K Elliott; Vishal Mehta; Steven Niederer; Christopher A Rinaldi Journal: Arrhythm Electrophysiol Rev Date: 2021-04
Authors: Mark K Elliott; Peggy Jacon; Baldeep Singh Sidhu; Lucy Jarrett Smith; Vishal S Mehta; Justin Gould; Angela W C Lee; Steven Niederer; Pascal Defaye; Christopher A Rinaldi Journal: Eur Heart J Case Rep Date: 2021-09-24
Authors: Jian Liang Tan; Justin Z Lee; Vittorio Terrigno; Benjamin Saracco; Shivam Saxena; Jonathan Krathen; Krystal Hunter; Yong-Mei Cha; Andrea M Russo Journal: CJC Open Date: 2021-06-16
Authors: Marek Jastrzębski; Haran Burri; Grzegorz Kiełbasa; Karol Curila; Paweł Moskal; Agnieszka Bednarek; Marek Rajzer; Pugazhendhi Vijayaraman Journal: Europace Date: 2022-01-04 Impact factor: 5.214